Literature DB >> 20117026

Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia.

Foteini Marantidou1, Antonis Dagklis, Evangelia Stalika, Penelope Korkolopoulou, Panagiota Korkolopoulou, Alina Saetta, Achilles Anagnostopoulos, Nikolaos Laoutaris, Kostas Stamatopoulos, Chrysoula Belessi, Zacharias Scouras, Efstratios Patsouris.   

Abstract

Activation-induced cytidine deaminase (AID) is critically implicated in somatic hypermutation (SHM) and class switch recombination (CSR). AID is expressed as a native transcript and as several splice variants, with as yet undefined roles. Chronic lymphocytic leukemia (CLL) leukemic B cells have also been shown to express AID transcripts, especially in cases with unmutated immunoglobulin (IG) genes. Therefore, AID expression in CLL might potentially be relevant to the disease. The available data on AID-mRNA splicing patterns in CLL are limited and conflicting. Here, we investigated AID-mRNA isoform expression in a series of 195 CLL patients and explored associations with IG gene mutational status and surface immunoglobulin (sIg) isotype expression. Full-length AID transcripts and two splice variants were detected in 110/91/95 cases, respectively. Co-expression of all three AID-mRNA isoforms was significantly more frequent (p<0.001) in cases with unmutated IGHV genes. No significant differences were identified between sIgG vs. sIgMD cases regarding the frequency of AID-mRNA expression. However, expression of at least one AID-mRNA isoform predominated among mutated IgG vs. mutated IgMD cases (p=0.05). These results attest to the biological heterogeneity of CLL and also indicate that AID splice variants may inhibit SHM in CLL cells of the unmutated subtype.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20117026     DOI: 10.1016/j.bcmd.2009.12.005

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  10 in total

Review 1.  Functions and regulation of the APOBEC family of proteins.

Authors:  Harold C Smith; Ryan P Bennett; Ayse Kizilyer; William M McDougall; Kimberly M Prohaska
Journal:  Semin Cell Dev Biol       Date:  2011-10-06       Impact factor: 7.727

2.  Structure-Based Design of First-Generation Small Molecule Inhibitors Targeting the Catalytic Pockets of AID, APOBEC3A, and APOBEC3B.

Authors:  Justin J King; Faezeh Borzooee; Junbum Im; Mahdi Asgharpour; Atefeh Ghorbani; Cody P Diamond; Heather Fifield; Lesley Berghuis; Mani Larijani
Journal:  ACS Pharmacol Transl Sci       Date:  2021-07-19

3.  IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions.

Authors:  Piers E M Patten; Charles C Chu; Emilia Albesiano; Rajendra N Damle; Xiao-Jie Yan; Dorothy Kim; Lu Zhang; Amanda R Magli; Jacqueline Barrientos; Jonathan E Kolitz; Steven L Allen; Kanti R Rai; Sergio Roa; Patricia K Mongini; Thomas MacCarthy; Matthew D Scharff; Nicholas Chiorazzi
Journal:  Blood       Date:  2012-10-15       Impact factor: 22.113

4.  Activation of Aicda gene transcription by Pax5 in plasmacytoma cells.

Authors:  Carissa Dege; James Hagman
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

5.  Splice variants of activation induced deaminase (AID) do not affect the efficiency of class switch recombination in murine CH12F3 cells.

Authors:  Cesare Sala; Giorgio Mattiuz; Silvia Pietrobono; Andrea Chicca; Silvestro G Conticello
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

6.  The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia.

Authors:  Chaohui Yuan; Charles C Chu; Xiao-Jie Yan; Davide Bagnara; Nicholas Chiorazzi; Thomas MacCarthy
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

7.  Mutagenic Activity of AID/APOBEC Deaminases in Antiviral Defense and Carcinogenesis.

Authors:  O N Shilova; D L Tsyba; E S Shilov
Journal:  Mol Biol       Date:  2022-02-12       Impact factor: 1.374

8.  Activation-induced deaminase and its splice variants associate with trisomy 12 in chronic lymphocytic leukemia.

Authors:  Kristina Zaprazna; Kamila Reblova; Veronika Svobodova; Lenka Radova; Vojtech Bystry; Jiri Baloun; Kristina Durechova; Nikola Tom; Tomas Loja; Martina Buresova; Kamila Stranska; Alexandra Oltova; Michael Doubek; Michael L Atchison; Martin Trbusek; Jitka Malcikova; Sarka Pospisilova
Journal:  Ann Hematol       Date:  2018-10-27       Impact factor: 3.673

Review 9.  AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression.

Authors:  Pablo Oppezzo; Marcelo Navarrete; Nicholas Chiorazzi
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

10.  Alternative splice variants of AID are not stoichiometrically present at the protein level in chronic lymphocytic leukemia.

Authors:  Stefan Rebhandl; Michael Huemer; Nadja Zaborsky; Franz Josef Gassner; Kemal Catakovic; Thomas Klaus Felder; Richard Greil; Roland Geisberger
Journal:  Eur J Immunol       Date:  2014-04-15       Impact factor: 5.532

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.